Stevanato Group S P A Quick Ratio (STVN) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Stevanato Group S p a   (NYSE: STVN)

Stevanato Group S P A 's Quick Ratio

STVN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 0.15 below Stevanato Group S P A average.

Within Medical Equipment & Supplies industry 94 other companies have achieved higher Quick Ratio than Stevanato Group S P A in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 0 to 1945.

Explain Quick Ratio?
How much Cash & cash equivalents STVN´s has?
What are STVN´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/STVN/financial-strength
https://api.csimarket.com/api/v1/companies/STVN/fundamentals
https://api.csimarket.com/api/v1/companies/STVN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
STVN Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change 18.84 %
Y / Y Cash & cash equivalent Change 50.68 %
Quick Ratio MRQ 0.15
STVN's Total Ranking # 1945
Seq. Current Liabilities Change 66.86 %
Seq. Cash & cash equivalent Change 4.79 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 424
Overall Market # 1945


Quick Ratio Statistics
High Average Low
0.49 0.27 0.12
(Dec 31 2022)   (Dec 31 2023)




Financial Statements
Stevanato Group S P A 's Current Liabilities $ 1,001 Millions Visit STVN's Balance sheet
Stevanato Group S P A 's Cash & cash equivalent $ 153 Millions Visit STVN's Balance sheet
Source of STVN's Sales Visit STVN's Sales by Geography


Cumulative Stevanato Group S P A 's Quick Ratio

STVN's Quick Ratio for the trailling 12 Months

STVN Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 14.51 %
Y / Y Cash & cash equivalent TTM Growth 37.09 %
Quick Ratio TTM 0.21
Total Ranking TTM # 2987
Seq. Current Liabilities TTM Growth 6.01 %
Seq. Cash & cash equivalent TTM Growth 9.54 %


On the trailing twelve months basis STVN Cash & cash equivalent soared by 50.68 % in Q4 2025 year on year, faster than Current Liabilities, this led to increase in in Stevanato Group S P A 's Quick Ratio to 0.21, Quick Ratio remained below STVN average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 166 other companies have achieved higher Quick Ratio than Stevanato Group S P A . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 0 to 2987.

Explain Quick Ratio?
How much Cash & cash equivalents STVN´s has?
What are STVN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 167
Healthcare Sector # 778
Within the Market # 2987


trailing twelve months Quick Ratio Statistics
High Average Low
0.49 0.31 0.12
(Dec 31 2022)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Nuo Therapeutics Inc   0.42 $ 0.549  Millions$ 1.306  Millions
Iridex Corp  0.41 $ 6.028  Millions$ 14.608  Millions
Nuwellis Inc   0.40 $ 1.085  Millions$ 2.686  Millions
Picard Medical Inc   0.40 $ 7.451  Millions$ 18.695  Millions
Alcon inc   0.37 $ 1,547.000  Millions$ 4,162.000  Millions
Masimo Corp  0.37 $ 152.300  Millions$ 411.000  Millions
Boston Scientific Corporation  0.36 $ 1,965.000  Millions$ 5,439.000  Millions
Vsee Health Inc   0.35 $ 5.266  Millions$ 15.056  Millions
Star Equity Holdings Inc   0.34 $ 10.269  Millions$ 29.826  Millions
Lifeward ltd   0.34 $ 4.338  Millions$ 12.847  Millions
Bioventus Inc   0.32 $ 51.238  Millions$ 160.380  Millions
Envoy Medical Inc   0.30 $ 3.739  Millions$ 12.487  Millions
Heartsciences Inc   0.30 $ 1.098  Millions$ 3.703  Millions
Adm Tronics Unlimited Inc   0.28 $ 0.299  Millions$ 1.057  Millions
Strata Skin Sciences Inc  0.28 $ 7.912  Millions$ 28.019  Millions
Ufp Technologies Inc   0.27 $ 20.301  Millions$ 74.862  Millions
Retractable Technologies Inc  0.27 $ 2.589  Millions$ 9.598  Millions
Milestone Scientific Inc   0.27 $ 1.113  Millions$ 4.131  Millions
FAMILY OFFICE OF AMERICA, INC.  0.27 $ 0.156  Millions$ 0.579  Millions
Dentsply Sirona Inc   0.24 $ 326.000  Millions$ 1,343.000  Millions
Accuray Incorporated  0.21 $ 41.295  Millions$ 199.439  Millions
Smith and Nephew Plc  0.21 $ 573.000  Millions$ 2,772.000  Millions
Invo Fertility Inc   0.20 $ 2.078  Millions$ 10.332  Millions
Bausch and Lomb Corp  0.20 $ 383.000  Millions$ 1,920.000  Millions
Zimmer Biomet Holdings Inc   0.19 $ 591.900  Millions$ 3,060.800  Millions
Intelligent Bio Solutions Inc   0.19 $ 1.020  Millions$ 5.351  Millions
Infusystem Holdings Inc  0.16 $ 3.186  Millions$ 20.182  Millions
Stevanato Group S p a   0.15 $ 153.276  Millions$ 1,001.452  Millions
Allurion Technologies Inc   0.14 $ 5.412  Millions$ 38.445  Millions
Stimcell Energetics Inc   0.14 $ 0.046  Millions$ 0.339  Millions

Date modified: 2026-10-05T11:03:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.